BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for MODERNA US INC. · Pharmaceuticals

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · Senate · $80,000.00 income · posted Apr 21, 2025

Lobbying activity 2

Health Issues

Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain

Foreign Relations

Issues related to international vaccine deployment

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.